Advised AstraZeneca on the strategic divestment of its industrial manufacturing site in Spain. The mandate involved evaluating the selling process against a potential factory shutdown. Responsibilities included screening the local market to identify optimal buyers and negotiating the transaction to ensure the best possible outcome for the seller, ultimately securing the sale to Biofabri.